The Engineered Lysin, CF-370, is Active Against Antibiotic-Resistant Gram-Negative Pathogens In vitro and Synergizes with Meropenem in Experimental Pseudomonas aeruginosa Pneumonia

By sjmartinez • February 18, 2024

Sauve K, Watson A, Oh JT, Swift S, Vila-Farres X, Abdelhady W, Xiong YQ, LeHoux D, Woodnutt G, Bayer AS, Schuch R. The Engineered Lysin, CF-370, is Active Against Antibiotic-Resistant Gram-Negative Pathogens In vitro and Synergizes with Meropenem in Experimental Pseudomonas aeruginosa Pneumonia. J Infect Dis. 2024 Feb 15:jiae027. doi: 10.1093/infdis/jiae027. Epub ahead of print. PMID: 38366561.

Tags: ESKAPE pathogens, Harbor UCLA, Infectious Diseases, Lysin, multidrug-resistance, pneumonia, pseudomonas aeruginosa, Publications, synergy

C3 glomerulopathy post kidney transplantation: A single center experience

Zuckerman J, Pham PT, Parakkal M, Velazquez AF, Sarkar M, Pablos MA, Bunnapradist S, Lum EL. C3 glomerulopathy post kidney transplantation: A single center experience.[...]

Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment

Munroe ES, Grandits GA, Hyzy RC, Prescott HC, Barrett TW, Dewar RL, Engen N, Goodman AL, Hatlen TJ, Highbarger H, Holland TL, Hughes G, Jensen[...]

The search for the ultra-elusive: Can computed cardiopulmonography enhance early detection of gas exchange abnormality?

Rossiter HB, Molgat-Seon Y. The search for the ultra-elusive: Can computed cardiopulmonography enhance early detection of gas exchange abnormality? Exp Physiol. 2025 Jun 17. doi:[...]